Indian Journal of Medical Microbiology Home 

ORIGINAL ARTICLE
[View FULLTEXT] [Download PDF]
Year : 2013  |  Volume : 31  |  Issue : 1  |  Page : 3--9

Evaluation and characterisation of A and B fragments of Corynebacterium diphtheriae toxin towards recombinant diphtheria vaccine

S Abulmagd1, M Emara2, S Aziz1, R El-Domany2 
1 Department of Research and Development, VACSERA, Cairo, Egypt
2 Department of Microbiology and Immunology, Helwan University, Cairo, Egypt

Correspondence Address:
R El-Domany
Department of Microbiology and Immunology, Helwan University, Cairo
Egypt

Background: Diphtheria is a highly communicable disease caused by toxin-producing strains of Corynebacterium diphtheriae. Objectives: To evaluate the efficacy of A and B subunits of diphtheria toxin (DT-A, DT-B) as potential vaccines against C. diphtheriae. A culture of C. diphtheriae (strain PW 8) was grown on Loeffler plates while Lingood medium was used for production of diphtheria toxin (DT). Materials and Methods: DT was purified and digested to obtain pure DT-A and DT-B and detoxified to obtain diphtheria toxin. Four groups of mice were immunised with different antigens (Ag) of C. diphtheriae. Results: The antibody (Ab) titres were significantly increased with immunised groups subsequent to three injections. On the other hand, Ab titres were estimated after the three immunisations and the levels of different Ab isotypes were comparatively measured. The levels of various isotypes immune responses showed variation between immunised groups where the IgG subclasses were significantly increased mainly with DPT immunised group. The IgM and IgA were significantly increased with DT-A more than others. Additionally, the evaluation of the cellular immune responses demonstrated that spleen cells from DPT and DT-A groups gave highly significant proliferative response with production of high levels of IL-2 and IFN-γ (Th1/Th2). Separation and purification of DT gene were performed using polymerase chain reaction (PCR) and sub-cloned in pGEM-T vector, for further studying of recombinant vaccine. Conclusion: Our results showed the possibility to prepare a potent recombinant vaccine containing whole DT gene or DT-A against C. diphtheriae or could be used in treatment of cancer as it give high levels of IL-2 and IFN-γ.

How to cite this article:
Abulmagd S, Emara M, Aziz S, El-Domany R. Evaluation and characterisation of A and B fragments of Corynebacterium diphtheriae toxin towards recombinant diphtheria vaccine.Indian J Med Microbiol 2013;31:3-9

How to cite this URL:
Abulmagd S, Emara M, Aziz S, El-Domany R. Evaluation and characterisation of A and B fragments of Corynebacterium diphtheriae toxin towards recombinant diphtheria vaccine. Indian J Med Microbiol [serial online] 2013 [cited 2020 Aug 9 ];31:3-9
Available from: http://www.ijmm.org/article.asp?issn=0255-0857;year=2013;volume=31;issue=1;spage=3;epage=9;aulast=Abulmagd;type=0